ERBB2 and breast carcinoma: Next, to test whether RIME technique could be applied to capture HER2 interactome from human breast cancer specimens, we conducted an HER2 RIME experiment using a HER2 strong positive and ER weak positive human breast cancer specimen (Case 1; HER2 3+, ER TS3).